Unknown

Dataset Information

0

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben.


ABSTRACT: BACKGROUND:Although amyloid beta (A?) imaging is widely used for diagnosing and monitoring Alzheimer's disease in clinical fields, paralleling comparison between 18F-flutemetamol and 18F-florbetaben was rarely attempted in AD mouse model. We performed a comparison of A? PET images between 18F-flutemetamol and 18F-florbetaben in a recently developed APPswe mouse model, C57BL/6-Tg (NSE-hAPPsw) Korl. RESULTS:After an injection (0.23 mCi) of 18F-flutemetamol and 18F-florbetaben at a time interval of 2-3 days, we compared group difference of SUVR and kinetic parameters between the AD (n?=?7) and control (n?=?7) mice, as well as between 18F-flutemetamol and 18F-florbetaben image. In addition, bio-distribution and histopathology were conducted. With visual image and VOI-based SUVR analysis, the AD group presented more prominent uptake than did the control group in both the 18F-florbetaben and 18F-flutemetamol images. With kinetic analysis, the 18F-florbetaben images showed differences in K1 and k4 between the AD and control groups, although 18F-flutemetamol images did not show significant difference. 18F-florbetaben images showed more prominent cortical uptake and matched well to the thioflavin S staining images than did the 18F-flutemetamol image. In contrast, 18F-flutemetamol images presented higher K1, k4, K1/k2 values than those of 18F-florbetaben images. Also, 18F-flutemetamol images presented prominent uptake in the bowel and bladder, consistent with higher bio-distribution in kidney, lung, blood and heart. CONCLUSIONS:Compared with 18F-flutemetamol images, 18F-florbetaben images showed prominent visual uptake intensity, SUVR, and higher correlations with the pathology. In contrast, 18F-flutemetamol was more actively metabolized than was 18F-florbetaben (Son et al. in J Nucl Med 58(Suppl 1):S278, 2017].

SUBMITTER: Son HJ 

PROVIDER: S-EPMC6063010 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents <sup>18</sup>F-flutemetamol and <sup>18</sup>F-florbetaben.

Son Hye Joo HJ   Jeong Young Jin YJ   Yoon Hyun Jin HJ   Lee Sang Yoon SY   Choi Go-Eun GE   Park Ji-Ae JA   Kim Min Hwan MH   Lee Kyo Chul KC   Lee Yong Jin YJ   Kim Mun Ki MK   Cho Kook K   Kang Do-Young DY  

BMC neuroscience 20180727 1


<h4>Background</h4>Although amyloid beta (Aβ) imaging is widely used for diagnosing and monitoring Alzheimer's disease in clinical fields, paralleling comparison between <sup>18</sup>F-flutemetamol and <sup>18</sup>F-florbetaben was rarely attempted in AD mouse model. We performed a comparison of Aβ PET images between <sup>18</sup>F-flutemetamol and <sup>18</sup>F-florbetaben in a recently developed APPswe mouse model, C57BL/6-Tg (NSE-hAPPsw) Korl.<h4>Results</h4>After an injection (0.23 mCi) of  ...[more]

Similar Datasets

| S-EPMC7486392 | biostudies-literature
| S-EPMC4338066 | biostudies-literature
| S-EPMC6437225 | biostudies-literature
| S-EPMC6132944 | biostudies-literature
| S-EPMC6057864 | biostudies-literature
| S-EPMC6942396 | biostudies-literature
| S-EPMC5318150 | biostudies-literature
| S-EPMC6297196 | biostudies-literature
| S-EPMC9221882 | biostudies-literature
| S-EPMC9997142 | biostudies-literature